Annual Rebalancing
EUR
Moderate Risk
1.7yr backtest
Analyse this portfolio

Performance Summary

Total Return+29.94%
Annualized Return+16.57%
Volatility+17.76%
Sharpe Ratio0.82
Max Drawdown+23.68%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
A diversified ETF portfolio targeting US tech, global developed, and emerging markets for long-term growth potential.
AssetTypeAllocationTER
XNAS.XETRA
Xtrackers Nasdaq 100 UCITS ETF 1C • IE00BMFKG444
ETF
60.0%0.2%
IS3N.XETRA
iShares Core MSCI Emerging Markets IMI UCITS • IE00BKM4GZ66
ETF
20.0%0.18%
XDPU.XETRA
Xtrackers S&P 500 UCITS ETF 4C • IE000Z9SJA06
ETF
10.0%0.03%
IXUA.XETRA
iShares MSCI World ex-USA UCITS ETF USD (Acc) • IE000R4ZNTN3
ETF
10.0%0.15%
Total100.0%0.17%

Performance

Portfolio Value Over Time
Starting with €10,000 investment → now worth €12,994.07
Histogram of Monthly Returns
The portfolio had a positive return during 13 of the 22 months (59%)
Monthly Returns Heatmap
Best month: +12.8% • Worst month: -8.4% • Best year: 2026 (+20.3%) • Worst year: 2025 (+8.0%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026+1.5%+0.2%-5.5%+12.8%+9.7%+1.6%-6.0%+3.4%+4.6%-2.1%--+20.3%
2025+1.4%-3.6%-8.4%-3.4%+8.0%+2.3%+5.4%-1.3%+4.4%+6.2%-1.9%-0.1%+8.0%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +23.68% • The longest drawdown period lasted for 6 months and was between February 2025 and September 2025. It reached a trough of -23.7%.

Detailed Metrics

Returns
Total Return
+29.94%
Annualized Return
+16.57%
Avg Monthly Return
+1.33%
Risk
Volatility (Annual)
+17.76%
Max Drawdown
+23.68%
Positive Months
59%
Average Drawdown
-4.8%
Risk-Adjusted
Sharpe Ratio
0.82
Risk-free rate: 2.0%
Sortino Ratio
0.77
Downside risk adjusted
Return/Volatility
0.93
Calmar Ratio
0.70
Return/Max Drawdown
Ulcer Index
6.11
Drawdown depth & duration
Martin Ratio
0.02
Return/Ulcer Index
Backtest Configuration
Initial Investment
€10,000
Final Value
€12,994.07
Backtest Period
2025-01-30 to 2026-10-16
1.7 years
Rebalancing
annual
Base Currency
EUR